168 related articles for article (PubMed ID: 38258075)
1. Transdermal Drug Delivery of Tazarotene: Determining Tazarotene's Potential in Local Transdermal Therapy.
Hamzehpour H; Óskarsdóttir Á; Jónsson H; Jónsdóttir F; Sigurjónsson ÓE; Snorradottir BS
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258075
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD; Matsumoto RM; Usansky JI
Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
[TBL] [Abstract][Full Text] [Related]
4. Development of a Tape-Stripping Liquid Chromatography-Mass Spectrometry Method for Evaluating Skin Deposition of Topical Tazarotene.
Draelos ZD; Draelos MM
J Drugs Dermatol; 2021 Oct; 20(10):1105-1111. PubMed ID: 34636513
[TBL] [Abstract][Full Text] [Related]
5. Development and Comparison of Nanosponge and Niosome based Gel for the Topical Delivery of Tazarotene.
Aggarwal G; Nagpal M; Kaur G
Pharm Nanotechnol; 2016; 4(3):213-228. PubMed ID: 29052500
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of tazarotene and its active metabolite tazarotenic acid in minipig plasma by LC-MS/MS and its application in pharmacokinetic study after topical administration of tazarotene gel.
Tong Y; Pan H; Sun C; Xin X; Ding L; Ma P
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():173-8. PubMed ID: 25550192
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
Datta D; Panchal DS; Venuganti VVK
Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
[TBL] [Abstract][Full Text] [Related]
8. Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.
Tang JY; Chiou AS; Mackay-Wiggan JM; Aszterbaum M; Chanana AM; Lee W; Lindgren JA; Raphael MA; Thompson BJ; Bickers DR; Epstein EH
Cancer Prev Res (Phila); 2014 Mar; 7(3):292-9. PubMed ID: 24441673
[TBL] [Abstract][Full Text] [Related]
9. Transdermal Drug Delivery: Determining Permeation Parameters Using Tape Stripping and Numerical Modeling.
Jonsdottir F; Snorradottir BS; Gunnarsson S; Georgsdottir E; Sigurdsson S
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145628
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Drug Delivery Kinetics to Epidermal Targets In Vivo.
Hoppel M; Tabosa MAM; Bunge AL; Delgado-Charro MB; Guy RH
AAPS J; 2021 Mar; 23(3):49. PubMed ID: 33782803
[TBL] [Abstract][Full Text] [Related]
11. Tazarotene--first of a new generation of receptor-selective retinoids.
Chandraratna RA
Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
[TBL] [Abstract][Full Text] [Related]
12. Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems.
Myburgh J; Liebenberg W; Willers C; Dube A; Gerber M
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896173
[TBL] [Abstract][Full Text] [Related]
13. PI3K-AKT signaling is a downstream effector of retinoid prevention of murine basal cell carcinogenesis.
So PL; Wang GY; Wang K; Chuang M; Chiueh VC; Kenny PA; Epstein EH
Cancer Prev Res (Phila); 2014 Apr; 7(4):407-17. PubMed ID: 24449057
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug-drug interaction for transdermal drug delivery in miniature pig.
Yu B; Ma P; Yuan L; Chen D; Yang J
Xenobiotica; 2015 May; 45(5):380-4. PubMed ID: 25410121
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
[TBL] [Abstract][Full Text] [Related]
16. Novel microemulsion-based gel formulation of tazarotene for therapy of acne.
Patel MR; Patel RB; Parikh JR; Patel BG
Pharm Dev Technol; 2016 Dec; 21(8):921-932. PubMed ID: 26334480
[TBL] [Abstract][Full Text] [Related]
17. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of pressure-sensitive adhesives as a pretreatment material before application of topical drug formulations and a peeling tape for excess stratum corneum layers.
Kikuchi K; Todo H; Sugibayashi K
Chem Pharm Bull (Tokyo); 2014; 62(6):559-67. PubMed ID: 24881662
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
Yu Z; Yu D; Walker PS; Tang-Liu DD
Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
